Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization.


Journal

Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 21 06 2018
revised: 14 10 2018
accepted: 28 10 2018
pubmed: 8 11 2018
medline: 18 6 2019
entrez: 8 11 2018
Statut: ppublish

Résumé

Sarcopenia is a prognostic factor in hepatocellular carcinoma (HCC) patients. HCC patients who underwent transcatheter arterial chemoembolization (TACE) are at a risk of muscle atrophy. We aimed to investigate the effects of in-hospital exercise on muscle mass and factors associated with muscle hypertrophy in HCC patients who underwent TACE. We enrolled 209 HCC patients who underwent TACE. Patients were classified into either an exercise (n = 102) or control (n = 107) group. In the exercise group, patients were treated with in-hospital exercise (median 2.5 metabolic equivalents/20-40 min/day). The effects of exercise on muscle mass were evaluated by changes in skeletal muscle index (ΔSMI) between before and after TACE. Factors associated with an increase in SMI were analyzed by logistic regression and decision-tree analyses. There was no significant difference in serum albumin and bilirubin levels between the two groups. ΔSMI was significantly higher in the exercise group than in the control group (0.28 cm In-hospital exercises increased muscle mass in HCC patients who underwent TACE. In addition, exercise was an independent factor for muscle hypertrophy. Thus, in-hospital exercise may prevent sarcopenia in HCC patients who underwent TACE.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Sarcopenia is a prognostic factor in hepatocellular carcinoma (HCC) patients. HCC patients who underwent transcatheter arterial chemoembolization (TACE) are at a risk of muscle atrophy. We aimed to investigate the effects of in-hospital exercise on muscle mass and factors associated with muscle hypertrophy in HCC patients who underwent TACE.
METHODS METHODS
We enrolled 209 HCC patients who underwent TACE. Patients were classified into either an exercise (n = 102) or control (n = 107) group. In the exercise group, patients were treated with in-hospital exercise (median 2.5 metabolic equivalents/20-40 min/day). The effects of exercise on muscle mass were evaluated by changes in skeletal muscle index (ΔSMI) between before and after TACE. Factors associated with an increase in SMI were analyzed by logistic regression and decision-tree analyses.
RESULTS RESULTS
There was no significant difference in serum albumin and bilirubin levels between the two groups. ΔSMI was significantly higher in the exercise group than in the control group (0.28 cm
CONCLUSIONS CONCLUSIONS
In-hospital exercises increased muscle mass in HCC patients who underwent TACE. In addition, exercise was an independent factor for muscle hypertrophy. Thus, in-hospital exercise may prevent sarcopenia in HCC patients who underwent TACE.

Identifiants

pubmed: 30402913
doi: 10.1111/jgh.14538
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

580-588

Subventions

Organisme : Program for Basic and Clinical Research on Hepatitis, Japan Agency for Medical Research and Development (AMED)
ID : JP18fk0210045

Informations de copyright

© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Auteurs

Shunji Koya (S)

Division of Rehabilitation, Kurume University Hospital, Kurume, Japan.

Takumi Kawaguchi (T)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.

Ryuki Hashida (R)

Division of Rehabilitation, Kurume University Hospital, Kurume, Japan.
Department of Orthopedics, School of Medicine, Kurume University, Kurume, Japan.

Keisuke Hirota (K)

Division of Rehabilitation, Kurume University Hospital, Kurume, Japan.

Masafumi Bekki (M)

Division of Rehabilitation, Kurume University Hospital, Kurume, Japan.
Department of Orthopedics, School of Medicine, Kurume University, Kurume, Japan.

Emiko Goto (E)

Department of Nursing, Kurume University Hospital, Kurume, Japan.

Maiko Yamada (M)

Department of Nursing, Kurume University Hospital, Kurume, Japan.

Masako Sugimoto (M)

Department of Nursing, Kurume University Hospital, Kurume, Japan.

Saki Hayashi (S)

Department of Nursing, Kurume University Hospital, Kurume, Japan.

Norihiro Goshima (N)

School of Medicine, Kurume University, Kurume, Japan.

Teruhito Yoshiyama (T)

School of Medicine, Kurume University, Kurume, Japan.

Takashi Otsuka (T)

School of Medicine, Kurume University, Kurume, Japan.

Ryosuke Nozoe (R)

Division of Rehabilitation, Kurume University Hospital, Kurume, Japan.

Ayu Nagamatsu (A)

Department of Nutrition, Kurume University Hospital, Kurume, Japan.

Dan Nakano (D)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.

Tomotake Shirono (T)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.

Shigeo Shimose (S)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.

Hideki Iwamoto (H)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.

Takashi Niizeki (T)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.

Hiroo Matsuse (H)

Division of Rehabilitation, Kurume University Hospital, Kurume, Japan.
Department of Orthopedics, School of Medicine, Kurume University, Kurume, Japan.

Hironori Koga (H)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.
Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan.

Hiroko Miura (H)

Department of Nursing, Kurume University Hospital, Kurume, Japan.

Naoto Shiba (N)

Division of Rehabilitation, Kurume University Hospital, Kurume, Japan.
Department of Orthopedics, School of Medicine, Kurume University, Kurume, Japan.

Takuji Torimura (T)

Division of Gastroenterology, Department of Medicine, School of Medicine, Kurume University, Kurume, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH